Department of Medicine, Patel Hospital, Karachi, Pakistan.
J Ayub Med Coll Abbottabad. 2023 Oct-Dec;35(Suppl 1)(4):S801-S803. doi: 10.55519/JAMC-S4-12094.
Hepatic hydrothorax refers to the presence of a pleural effusion (usually >500 mL) in a patient with cirrhosis who does not have other reasons to have a pleural effusion (e.g., cardiac, pulmonary, or pleural disease). Hepatic hydrothorax occurs in approximately 5-6% of patients with cirrhosis. It results from the ascitic fluid draining into the pleural cavity through the diaphragmatic defects. The presentation of patients with hepatic hydrothorax includes chest pain, hypoxemia, cough, shortness of breath and fatigue. The atypical feature, in this case, is the presence of hepatic hydrothorax in a patient with chronic liver disease without ascites. The management of hepatic hydrothorax is difficult. The initial treatment should be a low-salt diet plus diuretics. The best diuretic regimen is probably the combination of furosemide and spironolactone. However, about 25% of patients are refractory to this regimen, and additional therapy is indicated. This patient underwent thoracentesis, however, considering the re-accumulation of fluid, a pigtail catheter was placed which drained up to 8 liters of fluid.
肝性胸水是指在没有其他原因引起胸水(如心脏、肺部或胸膜疾病)的肝硬化患者中存在的胸水(通常 >500mL)。肝性胸水约发生在 5-6%的肝硬化患者中。它是由于腹水通过膈缺陷流入胸腔腔。肝性胸水患者的表现包括胸痛、低氧血症、咳嗽、呼吸急促和疲劳。在这种情况下,不典型的特征是慢性肝病患者存在肝性胸水而没有腹水。肝性胸水的治疗很困难。初始治疗应采用低盐饮食加利尿剂。最好的利尿剂方案可能是呋塞米和螺内酯的联合用药。然而,约 25%的患者对此方案有抗药性,需要额外的治疗。该患者接受了胸腔穿刺术,但考虑到液体的再积聚,放置了猪尾导管,引流了多达 8 升的液体。